News

An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the ...
Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data during ...
Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...
The FDA cleared the launch of a Phase 1 clinical trial to test cell therapy XS-228 in people with amyotrophic lateral ...
Company’s presentations highlight the power of mitochondrial medicine and protein homeostasis technologies to address ...
We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.” The ...
Candel’s pivotal phase 3 clinical trial in newly diagnosed ... iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid ...